drugset / Trial / NCT00612950

Beta-Cell Function After Near-Normalisation of Blood Glucose

NCT00612950

Completed 8 enrolled Hvidovre University Hospital
RandomizedSingle-groupSingle-blindBasic science

Summary

The incretin effect is attenuated in patients with type 2 diabetes mellitus partly due to impaired potentiation of beta-cell responsiveness to glucose by glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 respectively. The aim of the present study was to investigate whether 4 weeks of near-normalization of blood glucose could improve the insulin responses to GIP and GLP-1 in patients with type 2 diabetes.

Timeline

Start
2006-10
Primary completion
2007-02
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject GLP-1 Peptide 0.5 unknown
Subject Glucose-dependent Insulinotropic Polypeptide Peptide 1.5 unknown